✦ LIBER ✦

Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd

✍ Scribed by Hirohisa Nakamae; Hirohiko Shibayama; Mineo Kurokawa; Tetsuya Fukuda; Chiaki Nakaseko; Yoshinobu Kanda; Tadashi Nagai; Kazunori Ohnishi; Yasuhiro Maeda; Akira Matsuda; Taro Amagasaki; Masamitsu Yanada

Book ID: 107619286
Publisher: Carden Jennings Publishing
Year: 2011
Tongue: English
Weight: 289 KB
Volume: 93
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-011-0841-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib as the first-line treatment of

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

✍ Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

A phase II study of continuous infusion

A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804

✍ Richard M. Stone; Kathleen A. Donohue; Wendy Stock; Vera Hars; Charles A. Linker 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 281 KB